Drug intelligence / Profile preview

Fluocortolone

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Oral, Rectal
01

Overview

Fluocortolone is a synthetic glucocorticoid corticosteroid used primarily as a moderately potent topical corticosteroid for the treatment of inflammatory skin conditions such as eczema, dermatitis, and psoriasis. It is also indicated for hemorrhoids, anal fissures, dermatoses, and proctitis. Fluocortolone exerts its anti-inflammatory effects by binding to glucocorticoid receptors in target cells (primarily skin cells), forming a steroid-receptor complex that translocates into the nucleus and modulates gene expression. This process inhibits the production of pro-inflammatory proteins while promoting anti-inflammatory proteins, thereby reducing inflammation, itching (pruritus), redness, and pain. The drug can be administered topically or orally; after oral administration up to 15% may be systemically absorbed[1][2][4][5][6][8].

Brand names
Ultralanum Plain
Other names
FluorocortoloneFlucortoloneFluocortolonaFluocortolonumSH 742SH742SH-7426-alpha-Fluoro-16-alpha-methyl-1-dehydrocorticosterone6-alpha-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Fluocortolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluocortolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call